Largest medical research grant to help ME/CFS and Long COVID research
Patients with Long COVID report similar symptoms to ME/CFS patients such as neurocognitive, immunological, gastrointestinal, and cardiovascular manifestations, which are also symptoms of ME/CFS. Griffith University’s research into the potential overlap between Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) received a $6.4 million grant from the Stafford Fox Medical Research Foundation. It will provide for a clinical trial using identified pharmacotherapeutic targets and the registered drug, low dose naltrexone (LDN), in a clinical trial for both ME/CFS and Long COVID patients. The clinical trial will be conducted with participants from Queensland, New South Wales, and Victoria with recruitment of volunteers to commence in the coming months.